Short-chain fatty acids (SCFAs) play a crucial role in maintaining homeostasis in humans,
therefore the importance of a good and reliable SCFAs analytical detection has raised a lot …

Nanotechnology has an increasingly large impact on a broad scope of biotechnological,
pharmacological and pure technological applications. Its current use in bioenergy …

Short-chain fatty acids (SCFAs) are produced by anaerobic gut microbiota in the large
bowel. Qualitative and quantitative measurements of SCFAs in the intestinal tract and the …

Research in obesity and metabolic disorders that involve intestinal microbiota demands
reliable methods for the precise measurement of the short-chain fatty acids (SCFAs) and …

Accumulating evidence shows indigenous gut microbes can interact with the human host
through modulation of serotonin (5-HT) signaling. Here we investigate the impact of the …

Biomedical research in areas such as metabolic disorders, neuromodulatory, and
immunomodulatory conditions involves lipid metabolism and demands a reliable and …

Short-chain fatty acids (SCFAs) in the gut are mainly produced by the anaerobic microbial
fermentation of unabsorbed dietary carbohydrates in the large bowel. Quantitative …

It is increasingly evident that the gut microbiota is involved in the regulation of multiple
mammalian metabolic pathways through a series of interactive host‐microbiota metabolic …

Background The role of gut microbiota in human health has been intensively studied and
more recently shifted from emphasis on composition towards function. Function is partly …

The butyrogenic genes from Clostridium difficile DSM 1296T have been cloned and
expressed in Escherichia coli. The enzymes acetyl-coenzyme A (CoA) C-acetyltransferase …